Jpmorgan Chase & CO Fortress Biotech, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.8 - $1.5 $27,530 - $51,619
-34,413 Reduced 77.29%
10,110 $8,000
Q1 2022

May 11, 2022
BUY
$1.24 - $2.75 $5,566 - $12,344
4,489 Added 11.21%
44,523 $61,000
Q4 2021

Feb 10, 2022
SELL
$2.42 - $3.65 $5,319 - $8,022
-2,198 Reduced 5.2%
40,034 $100,000
Q3 2021

Nov 12, 2021
BUY
$2.82 - $3.7 $119,094 - $156,258
42,232 New
42,232 $136,000

Others Institutions Holding FBIO

# of Institutions
5
Shares Held
862K
Call Options Held
0
Put Options Held
0
View Full List

About Fortress Biotech, Inc.

FBIO Quotes by TradingView
  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $155M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email